Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-02

Clinical Trial Update: Chidamide With R-CHOP Regimen for DLBCL Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating chidamide with R-CHOP for diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chidamide (chidamide)
  • R-CHOP

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN